TY - JOUR
T1 - Feasibility and safety of transaxillary robotic thyroidectomy in Japan – Comparison with video-assisted neck surgery in initial cases
AU - Tanabe, Yosuke
AU - Kuki, Tomoki
AU - Yamahara, Kohei
AU - Kato, Hisayuki
AU - Tateya, Ichiro
N1 - Publisher Copyright:
Copyright © 2025. Published by Elsevier B.V.
PY - 2025/12
Y1 - 2025/12
N2 - Objective : To evaluate the safety and feasibility of transaxillary robotic thyroidectomy (TART) in Japan by comparing early cases with video-assisted neck surgery (VANS). Methods : Single-center retrospective review of 31 consecutive thyroid lobectomies: 16 VANS (Nov 2020–Feb 2025) and 15 TART (Mar 2022–Feb 2025). TART used da Vinci Surgical system (da Vinci) Xi for early cases and predominantly da Vinci SP thereafter. Indications included differentiated cancer ≤4 cm, cN0, unilateral disease without extrathyroidal invasion, or follicular tumors 3–5 cm. Operative time, blood loss, hospital stay, complications, and cosmetic outcomes were evaluated and compared with statistical analysis. Results : All procedures were completed without conversion to open surgery. Blood loss (16.5 g vs 25.8 g) and length of stay (6.3 vs 6.1 days) were comparable. Complications included two transient recurrent laryngeal nerve palsies after VANS and, after TART, one axillary bleed controlled under local anesthesia and one lymphatic leak; overall rates were similar. High cosmetic satisfaction was reported in both cohorts. Conclusion : Early experience shows TART is feasible and safe in Japan, achieving perioperative outcomes comparable to VANS with excellent cosmetic results.
AB - Objective : To evaluate the safety and feasibility of transaxillary robotic thyroidectomy (TART) in Japan by comparing early cases with video-assisted neck surgery (VANS). Methods : Single-center retrospective review of 31 consecutive thyroid lobectomies: 16 VANS (Nov 2020–Feb 2025) and 15 TART (Mar 2022–Feb 2025). TART used da Vinci Surgical system (da Vinci) Xi for early cases and predominantly da Vinci SP thereafter. Indications included differentiated cancer ≤4 cm, cN0, unilateral disease without extrathyroidal invasion, or follicular tumors 3–5 cm. Operative time, blood loss, hospital stay, complications, and cosmetic outcomes were evaluated and compared with statistical analysis. Results : All procedures were completed without conversion to open surgery. Blood loss (16.5 g vs 25.8 g) and length of stay (6.3 vs 6.1 days) were comparable. Complications included two transient recurrent laryngeal nerve palsies after VANS and, after TART, one axillary bleed controlled under local anesthesia and one lymphatic leak; overall rates were similar. High cosmetic satisfaction was reported in both cohorts. Conclusion : Early experience shows TART is feasible and safe in Japan, achieving perioperative outcomes comparable to VANS with excellent cosmetic results.
KW - Complications
KW - Endoscopic thyroidectomy
KW - Robotic thyroidectomy
UR - https://www.scopus.com/pages/publications/105020927053
UR - https://www.scopus.com/pages/publications/105020927053#tab=citedBy
U2 - 10.1016/j.anl.2025.10.006
DO - 10.1016/j.anl.2025.10.006
M3 - Article
C2 - 41183426
AN - SCOPUS:105020927053
SN - 0385-8146
VL - 52
SP - 769
EP - 775
JO - Auris Nasus Larynx
JF - Auris Nasus Larynx
IS - 6
ER -